Using 889-S1 cells that express high levels of MHC I upon IFN-γ stimulation and display more aggressive tumour growth in nude mice than in C57BL/6 mice, we tested the impact of USP12 inhibition on the efficacy of anti-PD-1 therapy. Here, USP12 is linked to neoplasm.